409097-40-1

Upstream product

• 409097-33-2 tert-butyl 2-[(4-formylphenyl)sulphanyl]-2-methylpropanoate 
• 34451-31-5 N-ethyl-O-methyl-hydroxylamine 
• 867314-37-2 2-[4-(aminomethyl)-phenylsulfanyl]-2-methyl-propionic acid tert-butylester hydrochloride 
• 6482-24-2 2-Bromoethyl methyl ether 

Downstream Products

• 867315-03-5 tert-butyl 2-[(4-{[(2-methoxyethyl)(prop-2-yn-1-yl)amino]methyl}phenyl)thio]-2-methylpropionate 
• 881687-22-5 tert-butyl-2-[(4-{[(6-chloropyrimidin-4-yl)(2-methoxyethyl)amino]methyl}phenyl)thio]-2-methyl-propanoate 
• 881687-37-2 tert-butyl-2-[(4-{[(2-chloropyrimidin-4-yl)(2-methoxyethyl)amino]methyl}phenyl)thio]-2-methyl-propanoate 
• 867314-30-5 2-[(4-{[(2-ethoxy-2-oxoethyl)(2-methoxyethyl)amino]methyl}phenyl)thio]-2-methyl-propionic acid tert-butylester 

Relevant academic research and scientific papers

NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE AS PPAR-ALPHA MODULATORS

The invention relates to novel pyrimidine derivatives of general formula (I), methods for the production thereof, their use for treating and/or preventing diseases, and to their use for producing medicaments for treating and/or preventing diseases, preferably for treating and/or preventing cardiovascular diseases, particularly dyslipidemia, arteriosclerosis, insufficiency of the heart, thrombosis and metabolic syndrome.

NOVEL OXADIAZINONE DERIVATIVES AND USE THEREOF AS PPAR-ALPHA MODULATORS

The invention relates to novel 1,3,4-oxadiazine-5-on derivatives of general formula (I), methods for the production thereof, the use thereof for treating and/or preventing diseases, and the use thereof for producing medicaments used for the treatment and/

PHENYLTHIOACETIC ACID DERIVATIVES AND USE THEREOF

The invention relates to novel phenylthioacetic acid derivatives of formula (I), to a method for the production thereof, to the use thereof for the treatment and/or prophylaxis of diseases, in addition to the use thereof in the production of medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prevention of cardiovascular diseases, in particular dyslipidaemia and arteriosclerosis. The compounds act as modulators for the PRAR-alpha receptor.

Propionic acid derivatives

The present application relates to novel potent PPAR-alpha-activating compounds for treating, for example, coronary heart disease, and to their preparation.